May 13, 2022
The US Food and Drug Administration (FDA) has approved an orally administered version of edaravone (Radicava ORS) for adults with amyotrophic lateral sclerosis (ALS). Edaravone is […]
May 6, 2022
The US Food and Drug Administration (FDA) today warned clinicians of a potential risk for patient exposure to toxic compounds associated with the use of certain […]
May 5, 2022
The US Food and Drug Administration (FDA) has granted standard approval to fam-trastuzumab deruxtecan-nxki (Enhertu) for patients with unresectable or metastatic HER2-positive breast cancer who have […]
May 4, 2022
The US Food and Drug Administration (FDA) has cleared the first in vitro diagnostic to aid in the early detection of Alzheimer’s disease (AD) The Lumipulse […]
May 4, 2022
The US Food and Drug Administration (FDA) has approved two vonoprazan-based treatments for Helicobacter pylori infection: Voquezna Triple Pak (vonoprazan, amoxicillin, clarithromycin) and Voquezna Dual Pak […]
May 3, 2022
The US Food and Drug Administration (FDA) has approved oral trientine tetrahydrochloride (Cuvrior, Orphalan) for the treatment of adults with stable Wilson’s disease who are decoppered […]
April 29, 2022
Patients implanted with the Medtronic Heartware Ventricular Assist Device (HVAD) System who develop pump thrombosis could have a welding defect in the internal pump causing the […]
April 29, 2022
The US Food and Drug Administration (FDA) has approved mavacamten (Camzyos, Bristol Myers Squibb) to improve functional capacity and symptoms in adults with symptomatic New York […]
April 26, 2022
Medtronic has recalled the Harmony delivery catheter, part of the Harmony Transcatheter Pulmonary Valve (TPV) System, because the bond holding the capsule at the end of […]